运脾强生方提高腹膜透析患者生存质量的疗效观察
Effect of Yunpiqiangsheng Fang on Improving Life Quality of Peritoneal Dialysis Patients
-
摘要: 目的 观察运脾强生方对腹膜透析(PD)患者生存质量(QOL)的影响。方法 共55例患者随机分为2组,治疗组26例,对照组29例。在西医基础治疗与常规PD治疗的前提下,治疗组加用运脾强生方,疗程3个月。观察治疗后KDQOL-SFTM1.3量表评分、营养指标(Hb、Alb、pre-A、TSF、MAC、MAMC、MQSGA)、代谢指标(TC、TG、Ca2+、P3+、PTH)及透析相关指标(BUN、Scr、KT/V、Ccr)的变化。结果 ①治疗组能够改善KDQOL-SFTM1.3量表总体评分,总有效率为83.3%,优于对照组(P<0.01),尤其在改善患者症状与一般健康状况、改善睡眠、减轻肾病对生活的影响、增强体力方面(P<0.05)。② 治疗组治疗后MQSGA与治疗前比较明显下降(P<0.01),Hb、Alb、pre-A、TSF上升(P<0.05),其中MQSGA、Hb、pre-A、TSF的变化优于对照组(P<0.05)。③2组TC、TG、Ca2+、P3+、PTH组内与组间比较无统计学意义(P>0.05)。④ 治疗组治疗后BUN较治疗前下降(P<0.05),其下降幅度优于对照组(P<0.05),2组Scr、KT/V、Ccr组内与组间比较无统计学意义(P>0.05)。结论 运脾强生方有助于提高PD患者的QOL,其作用与该方能够增进食欲,增强胃肠消化吸收能力,调节脏腑整体功能,进而改善患者的营养状况有关。Abstract: OBJECTIVE To observe the effect of Yunpiqiangsheng Fang on improving quality of life (QOL) of peritoneal dialysis (PD) patients. METHODS 55 patients were divided into treatment group (26) and control group (29). Control group received western medicine and conventional PD treatment apart from which treatment group was added Yunpiqiangsheng Fang as well for three months. After the treatment, changes in KDQOL-SFTM1.3 scale score, nutrition indicators (Hb, Alb, pre-A, TSF, MAC, MAMC, MQSGA), metabolic parameters (TC, TG, Ca2+, P3+, PTH) and dialysis-related indicators (BUN, Scr, KT / V, Ccr) were observed. RESULTS ① Treatment group can increase KDQOL-SFTM1.3 scale score with total effective rate 83.3 %, superior to control group (P<0.01) especially in improving the symptoms, health condition and sleep, relieving the impact of kidney disease for life, and enhancing strengh(P<0.05). ② After treatment, MQSGA in treatment group significantly decreased (P<0.01) while Hb, Alb, pre-A, TSF increased (P<0.05) compared with that before treatment. The changes of MQSGA, Hb, pre-A, TSF are better than that of control group (P<0.05). ③ There is no statistically significant difference in TC, TG, Ca2+, P3+, PTH among the groups (P>0.05). ④ BUN in treatment group is decreased (P<0.05) whose change is larger than that of control group (P<0.05). There is no statistically significant difference in Scr,KT/V,Ccr among the groups (P>0.05). CONCLUSION Yunpiqiangsheng Fang can help improve PD patients' QOL, which plays an important role in increasing appetite, enhancing digestion and absorption, regulating overall function of organs, thereby improving patients' nutrition.